Content area

Abstract

In this project, five different nanoparticles based on different ratios of iron, zinc, and manganese were synthesized to form Znx Mn1-X Fe2O4. Then, one of them was selected and polyethylene glycol was conjugated to its surface using tartaric acid to improve its biocompatibility. Also, to improve the target ability of the prepared polyethylene glycol conjugated Znx Mn1-X Fe2O4 as a nano-platform, folic acid was used as a targeting agent. The nano-platform was characterized using different techniques such as X-ray diffractometey, vibrating-sample magnetometer, ultraviolet–visible spectroscopy, field emission-scanning electron microscopy, Fourier-transform infrared spectroscopy and thermogravimetric analysis. In vivo and in vitro tests including hemolysis, blood aggregation and lethal dose showed that Zn0.5Mn0.5 Fe2O4 were the most suitable photosensitizers among all. Also, in vivo and in vitro biocompatibility analysis revealed that incorporation of polyethylene glycol can significantly improve the biocompatibility of the nano-platforms. The cytotoxicity results revealed that cell viability of cancerous cells was lower when the nano-platform was coated with folic acid and poly ethylene glycol under irradiation of visible light while whiteout shining the light, the cell viability was almost 100% for polyethylene coated nano-platform. These results can prove the great potential of folic acid to improve the photodynamic therapy performance of Zn0.5Mn0.5 Fe2O4.

Details

Title
Breast Cancer Therapy: Harnessing Biocompatible Zinc-manganese Nano-platform for Dual-targeted Photodynamic Therapy
Author
Zamani-Roudbaraki, Mostafa 1 ; Aghajanzadeh-Kiyaseh, Mozhgan 1 ; Shahangian, S. Shirin 2 ; Jashnani, Setare 1 ; Khoramabadi, Hossein 1 ; Shirini, Farhad 1 

 University of Guilan, Department of Organic Chemistry, Faculty of Chemistry, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250) 
 University of Guilan, Department of Biology, Faculty of Sciences, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250) 
Volume
34
Issue
10
Pages
4950-4960
Publication year
2024
Publication date
Oct 2024
Publisher
Springer Nature B.V.
Place of publication
New York
Country of publication
Netherlands
ISSN
15741443
e-ISSN
15741451
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2024-06-16
Milestone dates
2024-04-23 (Registration); 2023-12-06 (Received); 2024-04-23 (Accepted)
Publication history
 
 
   First posting date
16 Jun 2024
ProQuest document ID
3267008940
Document URL
https://www.proquest.com/scholarly-journals/breast-cancer-therapy-harnessing-biocompatible/docview/3267008940/se-2?accountid=208611
Copyright
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
Last updated
2025-10-30
Database
ProQuest One Academic